- SPOT
Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 22,183.35 | 22,133.81 |
| R2 | 22,289.7 | 22,193.34 |
| R3 | 22,435.6 | 22,289.7 |
| PP | 22,037.45 | 22,037.45 |
| S1 | 22,183.35 | 22,133.81 |
| S2 | 21,785.2 | 21,881.56 |
| S3 | 21,678.85 | 21,785.2 |
FAQs
What is the Nifty Pharma Index?
The Nifty Pharma Index comprises pharmaceutical companies listed on the National Stock Exchange (NSE) of India. It tracks the performance of major pharmaceutical firms involved in drug manufacturing, research and development, and healthcare solutions. Investing in the Nifty Pharma Index provides exposure to India's pharmaceutical sector, which is renowned globally for its research capabilities and generic drug production. This index serves as a benchmark for monitoring the performance of pharmaceutical stocks in the Indian equity market, reflecting trends in healthcare and regulatory environments.
How many companies are part of the Nifty Pharma Index?
The Nifty Pharma Index includes 21 leading pharmaceutical companies such as Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Divi's Laboratories Ltd, and Sun Pharmaceutical Industries Ltd. These companies are selected based on their market capitalisation and significance within the pharmaceutical industry. The index is reviewed semi-annually to ensure it accurately reflects market conditions and company performance. Each constituent's weightage is determined by its free float market capitalisation, offering investors a comprehensive view of the pharmaceutical sector's performance and growth potential in India.